NASDAQ:OGI Organigram (OGI) Stock Price, News & Analysis $1.63 +0.01 (+0.62%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$1.61▼$1.6550-Day Range$1.49▼$1.9952-Week Range$0.97▼$2.91Volume350,500 shsAverage Volume1.17 million shsMarket Capitalization$169.10 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Organigram alerts: Email Address Organigram MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestBearish5.21% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.57Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.32) to ($0.07) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.16 out of 5 starsMedical Sector923rd out of 936 stocksPharmaceutical Preparations Industry430th out of 436 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Organigram.Read more about Organigram's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted5.21% of the float of Organigram has been sold short.Short Interest Ratio / Days to CoverOrganigram has a short interest ratio ("days to cover") of 4.2.Change versus previous monthShort interest in Organigram has recently increased by 0.77%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldOrganigram does not currently pay a dividend.Dividend GrowthOrganigram does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for OGI. Previous Next 2.5 News and Social Media Coverage News SentimentOrganigram has a news sentiment score of 0.57. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Organigram this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for OGI on MarketBeat in the last 30 days. This is a decrease of -83% compared to the previous 30 days.MarketBeat Follows3 people have added Organigram to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Organigram insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.09% of the stock of Organigram is held by insiders.Percentage Held by InstitutionsOnly 34.63% of the stock of Organigram is held by institutions.Read more about Organigram's insider trading history. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Organigram are expected to grow in the coming year, from ($0.32) to ($0.07) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Organigram is -1.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Organigram is -1.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioOrganigram has a P/B Ratio of 0.66. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Organigram's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. About Organigram Stock (NASDAQ:OGI)Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as consumer channels. The company was incorporated in 2010 and is headquartered in Toronto, Canada.Read More OGI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OGI Stock News HeadlinesJuly 24 at 6:48 AM | finance.yahoo.comOrganigram to Bolster Auto-Flower and Rare Cannabinoid Portfolio with Partial Third Tranche Investment of US $1M into PhylosJuly 19, 2024 | americanbankingnews.comOrganigram (NASDAQ:OGI) Coverage Initiated by Analysts at Canaccord Genuity GroupJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.July 11, 2024 | benzinga.comA $2 Billion Opportunity In Cannabis: How A Tobacco Giant Is Helping Organigram Seize The German MarketJune 25, 2024 | businesswire.comOrganigram Invests in Sanity Group, a Leading German Cannabis CompanyMay 28, 2024 | businesswire.comOrganigram Signs Three Year Supply Agreement with Avida Medical in UKMay 14, 2024 | sfgate.comOrganiGram: Fiscal Q2 Earnings SnapshotMay 14, 2024 | msn.comOrganigram Reports 262% Higher Quarterly Net Loss YoY, Makes Progress In International MarketsJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.May 14, 2024 | businesswire.comOrganigram Reports Second Quarter Fiscal 2024 ResultsMay 8, 2024 | businesswire.comOrganigram to Report Second Quarter Fiscal 2024 Results on May 14, 2024April 27, 2024 | investorplace.comThe Top 3 Cannabis Stocks to Buy in April 2024April 26, 2024 | finance.yahoo.comAre Medical Stocks Lagging OrganiGram (OGI) This Year?April 11, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Tonix Pharma (TNXP), OrganiGram Holdings (OGI)April 10, 2024 | stockhouse.comOrganigram Recognized for Executive Gender Diversity by the Globe & Mail's Women Lead Here Report for the Fourth Consecutive YearApril 3, 2024 | finance.yahoo.comOrganigram’s Popular SHRED Brand Surpasses $200 Million in Yearly Retail SalesApril 3, 2024 | businesswire.comOrganigram's Popular SHRED Brand Surpasses $200 Million in Yearly Retail SalesApril 2, 2024 | businesswire.comOrganigram Successfully Closes Previously Announced Underwritten Public OfferingSee More Headlines Receive OGI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Organigram and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/14/2024Today7/26/2024Next Earnings (Estimated)8/01/2024Fiscal Year End9/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:OGI CUSIPN/A CIK1620737 Webwww.organigram.ca Phone(844) 644-4726FaxN/AEmployees860Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.94) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-184,340,000.00 Net Margins-188.38% Pretax MarginN/A Return on Equity-40.19% Return on Assets-34.70% Debt Debt-to-Equity RatioN/A Current Ratio3.47 Quick Ratio1.98 Sales & Book Value Annual Sales$120.01 million Price / Sales1.41 Cash FlowN/A Price / Cash FlowN/A Book Value$2.48 per share Price / Book0.66Miscellaneous Outstanding Shares103,740,000Free Float103,643,000Market Cap$169.10 million OptionableOptionable Beta1.06 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.Get This Free Report Key ExecutivesMs. Beena G. Goldenberg (Age 60)CEO & Director Comp: $352.27kMs. Helen Martin (Age 46)Chief Legal Officer & Corporate Secretary Comp: $223.52kMr. Timothy EmbergChief Commercial OfficerMr. Paolo De Luca C.A. (Age 51)C.F.A, Chief Strategy Officer Comp: $222.62kMr. Greg Guyatt C.A.CPA, Chief Financial OfficerMs. Nathalie BattenSenior Vice President of OperationsMr. Geoff RiggsChief Information OfficerMax SchwartzDirector of Investor RelationsMs. Megan Amber McCraeSenior Vice President of Marketing & CommunicationsMs. Katrina May McFaddenChief People OfficerMore ExecutivesKey CompetitorsArbutus BiopharmaNASDAQ:ABUSPhathom PharmaceuticalsNASDAQ:PHATIGM BiosciencesNASDAQ:IGMSGinkgo BioworksNYSE:DNAREGENXBIONASDAQ:RGNXView All CompetitorsInstitutional OwnershipCanton Hathaway LLCBought 22,000 shares on 7/22/2024Ownership: 0.040%Baader Bank AktiengesellschaftBought 52,852 shares on 7/17/2024Ownership: 0.244%Clear Harbor Asset Management LLCBought 32,750 shares on 7/17/2024Ownership: 0.032%Virtu Financial LLCBought 158,331 shares on 5/20/2024Ownership: 0.153%Tidal Investments LLCBought 1,737,876 shares on 5/17/2024Ownership: 1.681%View All Institutional Transactions OGI Stock Analysis - Frequently Asked Questions How have OGI shares performed this year? Organigram's stock was trading at $1.31 on January 1st, 2024. Since then, OGI shares have increased by 24.4% and is now trading at $1.63. View the best growth stocks for 2024 here. How were Organigram's earnings last quarter? Organigram Holdings Inc. (NASDAQ:OGI) announced its quarterly earnings data on Tuesday, May, 14th. The company reported ($0.12) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.06) by $0.06. The business earned $27.91 million during the quarter, compared to analysts' expectations of $28.27 million. Organigram had a negative net margin of 188.38% and a negative trailing twelve-month return on equity of 40.19%. When did Organigram's stock split? Organigram's stock reverse split on the morning of Friday, July 7th 2023. The 1-4 reverse split was announced on Friday, July 7th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, July 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split. Who are Organigram's major shareholders? Organigram's top institutional shareholders include Baader Bank Aktiengesellschaft (0.24%), Canton Hathaway LLC (0.04%) and Clear Harbor Asset Management LLC (0.03%). How do I buy shares of Organigram? Shares of OGI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Organigram own? Based on aggregate information from My MarketBeat watchlists, some other companies that Organigram investors own include KushCo (KSHB), Auxly Cannabis Group (CBWTF), Supreme Cannabis (SPRWF), Medical Marijuana (MJNA), CNBX Pharmaceuticals (CNBX) and MariMed (MRMD). This page (NASDAQ:OGI) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organigram Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Organigram With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.